¼¼°èÀÇ È¯ÀÚ °æÇè ±â¼ú ½ÃÀå
Patient Experience Technology
»óǰÄÚµå : 1798986
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 215 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ȯÀÚ °æÇè ±â¼ú ¼¼°è ½ÃÀåÀº 2030³â±îÁö 4¾ï 1,540¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 2¾ï 4,530¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ȯÀÚ °æÇè ±â¼ú ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 4¾ï 1,540¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ 2024-2030³â CAGRÀº 9.2%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀΠȯÀÚ °æÇè Á¶»ç´Â CAGR 11.3%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 1¾ï 2,370¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. µðÁöÅРȯÀÚ Âü¿© ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ CAGR·Î 10.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6,680¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 14.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ È¯ÀÚ °æÇè ±â¼ú ½ÃÀåÀº 2024³â¿¡ 6,680¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ 2024³âºÎÅÍ 2030³â±îÁö CAGR 14.5%¸¦ ´õµë¾î, 2030³â¿¡´Â ¿¹Ãø ½ÃÀå ±Ô¸ð 9,310¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 4.5%¿Í 8.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 6.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ È¯ÀÚ °æÇè ±â¼ú ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ȯÀÚ °æÇè ±â¼úÀº Äɾî ÄÁƼ´º¾ö Àü¹ÝÀÇ Âü¿©¸¦ ¾î¶»°Ô À籸¼ºÇϰí Àִ°¡?

ȯÀÚ °æÇè ±â¼úÀº º´¿ø Áß½ÉÀÇ ÆíÀǽü³¿¡¼­ ÇコÄɾî Àü¹Ý¿¡ °ÉÃÄ È¯ÀÚ Áß½ÉÀÇ Ä¡·á¸¦ Àü·«ÀûÀ¸·Î ½ÇÇöÇÏ´Â ¹æÇâÀ¸·Î ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ÀÌ ±¤¹üÀ§ÇÏ°í ºü¸£°Ô ¼ºÀåÇÏ´Â ºÐ¾ß¿¡´Â Ä¿¹Â´ÏÄÉÀ̼Ç, ¸¸Á·µµ, Çǵå¹é, ³»ºñ°ÔÀ̼Ç, ÄɾîÀÇ °³ÀÎÈ­¸¦ ÃÖÀûÈ­ÇÏ´Â µðÁöÅÐ µµ±¸°¡ Æ÷ÇԵ˴ϴÙ. üũÀΠŰ¿À½ºÅ©¿Í ¸ð¹ÙÀÏ ¾È³» ¾ÛºÎÅÍ AI ±â¹Ý 꺿°ú ½Ç½Ã°£ Çǵå¹é Ç÷§Æû¿¡ À̸£±â±îÁö, ȯÀÚ °æÇè ±â¼úÀº Áø·á ¿©Á¤À» º¸´Ù ¿øÈ°ÇÏ°Ô Çϰí, ´õ ¸¹Àº Á¤º¸¸¦ Á¦°øÇϸç, ´õ ¸¹Àº »óÈ£ÀÛ¿ëÀ» ÅëÇØ ±Ã±ØÀûÀ¸·Î ÀÓ»ó °á°ú¿Í ¾÷¹« È¿À²¼ºÀ» °³¼±ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ±×¸®°í ¾÷¹« È¿À²¼ºÀ» °³¼±ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.

ÇコÄɾîÀÇ ¼ÒºñÀÚÈ­ Ãß¼¼¿¡ µû¶ó ȯÀÚµéÀÇ ±â´ë´Â Åõ¸í¼º, ÆíÀǼº, µðÁöÅÐ ¿ª·® °­È­·Î ¿Å°Ü°¡°í ÀÖ½À´Ï´Ù. ȯÀÚµéÀº ÀÌÁ¦ ÀºÇà, ¼Ò¸ÅÁ¡, ¿©Çà ¼­ºñ½º¿¡¼­ ¹Þ´Â °Í°ú °°Àº °æÇè, Áï Áï°¢ÀûÀÎ Á¢±Ù, µðÁöÅÐ Á¦¾î, 24½Ã°£ 365ÀÏ Áö¿øÀ» ¿øÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú, º´¿ø°ú ÀÇ·á ½Ã½ºÅÛÀº ¿¹¾à ¿¹¾à, °áÁ¦ Æ÷ÅÐ, °Ç°­ ±³À° ¸ðµâ, Åð¿ø ÈÄ Áöħ, ´ÜÀÏ ¸ð¹ÙÀÏ ¾Û ÀÎÅÍÆäÀ̽º¸¦ ÅëÇÑ ¿ø°Ý Áö¿ø µîÀ» ÅëÇÕÇÑ ÅëÇÕ È¯ÀÚ Âü¿© Ç÷§Æû¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.

ȯÀÚ º¸°í °æÇè ÁöÇ¥(PREM)´Â Áß¿äÇÑ Ç°Áú º¥Ä¡¸¶Å©·Î¼­ ÁöÁö¸¦ ¹Þ°í ÀÖÀ¸¸ç, º´¿øÀÇ ¼øÀ§»Ó¸¸ ¾Æ´Ï¶ó °¡Ä¡ ±â¹Ý Áø·á ¸ðµ¨ ÇÏ¿¡¼­ÀÇ »óȯ¿¡µµ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀº µðÁöÅÐ Á¶»ç µµ±¸, ½Ç½Ã°£ NPS(Net Promoter Score) ´ë½Ãº¸µå, °ÅÀÇ ½Ç½Ã°£À¸·Î ¸¸Á·µµ¸¦ ÃßÀûÇÒ ¼ö ÀÖ´Â ºÐ¼® Ç÷§ÆûÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ¼­ºñ½º º´¸ñ Çö»óÀ» °¨ÁöÇϰí, ´ë±â ½Ã°£À» ÁÙÀ̰í, Á÷¿øÀÇ ´ëÀÀ·ÂÀ» Çâ»ó½Ã۸ç, ´õ ¸¹Àº Á¢Á¡ÀÌ ÇÊ¿äÇÑ °íÀ§Çè ȯÀÚ¸¦ ã¾Æ³»´Â µ¥ µµ¿òÀ» ÁÖ¸ç, ¿À´Ã³¯ °á°ú Áß½ÉÀÇ Áø·á ȯ°æ¿¡¼­ °æÀï ¿ìÀ§¸¦ Á¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ µµ±¸°¡ µÇ°í ÀÖ½À´Ï´Ù.

ÆäÀ̼¾Æ® ¿©Á¤À» °­È­ÇÏ´Â µðÁöÅÐ ÀÎÅÍÆäÀ̽º¿Í AI µµ±¸´Â?

¼¿ÇÁ¼­ºñ½º Ű¿À½ºÅ©, ħ´ë ¿· ÀÎÆ÷Å×ÀÎ¸ÕÆ® ½Ã½ºÅÛ, ´Ù±¹¾î °¡»ó ºñ¼­ µî ȯÀÚµéÀ» À§ÇÑ µðÁöÅÐ ÀÎÅÍÆäÀ̽ºÀÇ µµÀÔÀº ȯÀÚ¿Í º´¿ø ¹× Áø·á¼Ò¿ÍÀÇ °ü°è ¹æ½ÄÀ» Å©°Ô ¹Ù²Ù°í ÀÖ½À´Ï´Ù. ¾ó±¼ ÀÎÁõ, ºñÁ¢ÃË½Ä Ã¼Å©ÀÎ, º¸Çè ÀÎÁõÀ» °®Ãá Ű¿À½ºÅ©´Â µµÂø ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÏ°í °ü¸® ºÎ´ãÀ» ÁÙÀÔ´Ï´Ù. ¸ð¹ÙÀÏ ±â¹Ý ±æ ¾È³» ¼Ö·ç¼ÇÀº ȯÀÚµéÀÌ ³ÐÀº º´¿ø ³»¸¦ À̵¿ÇÏ´Â µ¥ µµ¿òÀ» ÁÖ¾î È¥¶õ°ú ½ºÆ®·¹½º¸¦ ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. ÀÎÅÍ·¢Æ¼ºê °Å½Ç¿ë ÅÂºí¸´°ú ÀÎÆ÷Å×ÀÎ¸ÕÆ® ÄܼÖÀº °Ç°­ ÄÁÅÙÃ÷, ½Ä»ç ¿É¼Ç, ÄÉ¾î ½ºÄÉÁÙ¿¡ ´ëÇÑ ¾×¼¼½º¸¦ Á¦°øÇÏ¿© ÀÔ¿ø ȯÀڵ鿡°Ô ÈûÀ» ½Ç¾îÁÖ°í ¸¸Á·µµ Á¡¼ö¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

ÀΰøÁö´ÉÀº 꺿, ¿¹Ãø ºÐ¼®, ÀÚ¿¬¾î 󸮸¦ ÅëÇØ ȯÀÚ °æÇè Ç÷§ÆûÀÇ ¿µÇâ·ÂÀ» ÁõÆø½Ã۰í ÀÖ½À´Ï´Ù. AI 꺿Àº ¼±º°Áø·á¿Í ½ºÄÉÁÙ¸µ¿¡ »ç¿ëµÇ¸ç, »ç¶÷ÀÇ °³ÀÔ ¾øÀÌ È¯ÀÚ¸¦ ÀûÀýÇÑ ÀÇ·á±â°ü°ú °Ë»ç·Î ¾È³»ÇÕ´Ï´Ù. À½¼º ºñ¼­ ¹× NLP ¿£ÁøÀº ´Ù±¹¾î Áö¿ø, ½Ã°¢ Àå¾Ö ȯÀÚÀÇ Á¢±Ù¼º, ±¸µÎ Çǵå¹éÀÇ ½Ç½Ã°£ Àü»ç¸¦ À§ÇØ µµÀԵǾú½À´Ï´Ù. ¿¹Ãø ¸ðµ¨Àº ÀÌÅ», ¹«´Ü°á¼®, ºñ¼øÀÀ À§ÇèÀÌ Àִ ȯÀÚ¸¦ ½Äº°Çϰí, ¹®ÀÚ, ÀüÈ­, ¾Û ¾Ë¸²À» ÅëÇØ Àû±ØÀûÀÎ ¾Æ¿ô¸®Ä¡ ¹× °³ÀÎÈ­µÈ Áö¿øÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.

¶ÇÇÑ, °¡»ó Áø·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µ Ç÷§ÆûÀº ȯÀÚ °æÇèÀ» º´¿ø ¹Û±îÁö È®ÀåÇϰí ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ¹× ÀçÅÃÀÇ·á ŰƮ´Â ȸº¹ ÁøÇà »óȲÀ» ÃßÀûÇϰí, Áõ»ó ¾÷µ¥ÀÌÆ®¸¦ Àü¼ÛÇϰí, º¹¾à ¾Ë¸²À» Á¦°øÇÔÀ¸·Î½á º¹¾à ¼øÀÀµµ¿Í Ä¡·á ¿¬¼Ó¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ȯÀÚ Æ÷ÅÐÀº ºñµ¿±â½Ä Ä¿¹Â´ÏÄÉÀ̼Ç, ¿ø°ÝÁø·á ±â·Ï, ó¹æÀü º¸Ãæ, µðÁöÅÐ ÀÇ·á ±â·Ï¿¡ ´ëÇÑ ¾×¼¼½º¸¦ ÅëÇÕÇÏ¿© »ç¿ëÀÚ¿¡°Ô Åõ¸í¼º°ú °ü¸® ´É·ÂÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸µéÀº ÀüüÀûÀ¸·Î ÀϽÃÀûÀÎ Ä¡·á¿Í Áö¼ÓÀûÀÎ Ä¡·áÀÇ °£±ØÀ» ¸Þ¿ì°í, °æÇèÀ» º¸´Ù Á¾´ÜÀûÀÌ°í °ü°èÀûÀÎ °ÍÀ¸·Î ¸¸µé¾î ÁÝ´Ï´Ù.

¾î¶² ÀÇ·á ¼­ºñ½º Á¦°øÀÚ À¯Çü°ú Áö¿ª ÀÇ·á ½Ã½ºÅÛÀÌ Ã¤ÅÃÀ» ÁÖµµÇϰí Àִ°¡?

ȯÀÚ °æÇè ±â¼ú µµÀÔÀº ´ëÇü º´¿ø ½Ã½ºÅÛ, Çмú ÀÇ·á ¼¾ÅÍ, ¿Ü·¡ Áø·á üÀÎ, ÁöºÒÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚÀÇ ÇÏÀ̺긮µå ³×Æ®¿öÅ©°¡ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÅëÇÕ ÀÇ·á Á¦°ø ³×Æ®¿öÅ©(IDN)´Â º¸´Ù ±¤¹üÀ§ÇÑ µðÁöÅÐ ÇÁ·ÐÆ® µµ¾î Àü·«ÀÇ ÀÏȯÀ¸·Î µðÁöÅÐ °æÇè Ç÷§ÆûÀ» ¿ì¼±½ÃÇÏ´Â °æÇâÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ç÷§ÆûÀº ȯÀÚ¿¡ ´ëÇÑ ¾Æ¿ô¸®Ä¡, Ä¿¹Â´ÏÄÉÀ̼Ç, ¼·Ãë, ÈÄ¼Ó Á¶Ä¡¸¦ Áß¾Ó ÁýÁßÈ­ÇÏ¿© Æ÷ǽ·¹ÀÌ¼Ç Çコ ¸ñÇ¥¿Í °¡Ä¡ ±â¹Ý »óȯ ¸ðµ¨¿¡ ºÎÇÕÇÕ´Ï´Ù.

¿Ü·¡ ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿Í ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ´Â ÀÚµ¿ Çǵå¹é ½Ã½ºÅÛ°ú ¼¿ÇÁ¼­ºñ½º µµ±¸¿¡ ÅõÀÚÇÏ¿© 󸮷®À» ÃÖÀûÈ­Çϰí ȯÀÚ Ãæ¼ºµµ¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á Á¦°øÀÚ ¹× µðÁöÅÐ ¿ì¼± Ŭ¸®´ÐÀº °¡»ó ´ë±â½Ç, 꺿À» ÅëÇÑ ¼±º°Áø·á, µðÁöÅÐ µ¿ÀǼ­ µîÀ» ÇÙ½É ¼­ºñ½º¿¡ ÅëÇÕÇϰí, ÀÌ·¯ÇÑ ±â¼úÀ» ±âº»ÀûÀ¸·Î µµÀÔÇϰí ÀÖ½À´Ï´Ù. ÇÑÆí, À¯·á ÀÇ·á±â°üµµ ȸ¿ø ¾Û, °¡»ó ÄÚĪ, °í°´ ¼­ºñ½º AI ÅøÀ» Á¦°øÇÔÀ¸·Î½á ȯÀÚ °æÇè ºÐ¾ß¿¡ ÁøÃâÇÏ¿© ȯÀÚ À¯Áö¿Í ¸¸Á·µµ¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î´Â ¹Ì±¹ÀÌ °¡Ä¡ ±â¹Ý »óȯ Àǹ«, °æÀï °ø±ÞÀÚ »ýŰè, ȯÀÚµéÀÇ ³ôÀº ±â´ëÄ¡·Î ÀÎÇØ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â ¿µ±¹ÀÇ NHSX ÇÁ·Î±×·¥, ÇÁ¶û½ºÀÇ Ma Sante 2022 µî ȯÀÚ Áß½ÉÀÇ µðÁöÅÐ ÀüȯÀ» °­Á¶ÇÏ´Â µðÁöÅÐ Çコ Àü·«À¸·Î µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ƯÈ÷ Áß±¹ µµ½Ã Áö¿ª, ½Ì°¡Æ÷¸£, Àεµ¿¡¼­ ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí, ¸ð¹ÙÀÏ ¿ì¼±ÀÇ È¯ÀÚ Âü¿©¸¦ ÃËÁøÇÏ´Â µî °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿Àº ȯÀÚ °æÇè KPI¸¦ Æ÷ÇÔÇÑ º´¿ø Çö´ëÈ­ ÇÁ·ÎÁ§Æ®¸¦ Á¤ºÎ°¡ Áö¿øÇÏ´Â ½ÅÈï ½ÃÀåÀÔ´Ï´Ù.

ȯÀÚ °æÇè ±â¼ú ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¼¼°è ȯÀÚ °æÇè ±â¼ú ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº °¡Ä¡ ±â¹Ý Äɾ ´ëÇÑ °ü½É Áõ°¡, ¼ÒºñÀÚÀÇ ±â´ëÄ¡ »ó½Â, ÀÇ·á ¼­ºñ½º Á¦°øÀÇ µðÁöÅÐ Çõ½Å, ½Ç½Ã°£ Çǵå¹é ¹× °³ÀÎÈ­µÈ Áö¿ø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÔ´Ï´Ù. ÇコÄÉ¾î °æÀïÀÌ Ä¡¿­ÇØÁü¿¡ µû¶ó ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀº ȯÀÚ °æÇè µµ±¸¸¦ ÄÄÇöóÀ̾𽺠¹× ¸¸Á·µµ»Ó¸¸ ¾Æ´Ï¶ó ¼ºÀå, À¯Áö, Ä¡·á Á¶Á¤À» À§ÇÑ Áß¿äÇÑ ¼ö´ÜÀ¸·Î ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù.

Á¤ºÎÀÇ Àǹ«È­ ¹× ÀÎÁõ ±â°üÀº ȯÀÚ °æÇè Á¡¼ö¸¦ ¼º°ú ÃøÁ¤ ÇÁ·¹ÀÓ¿öÅ©¿¡ ÅëÇÕÇϰí, ½Ç½Ã°£ PREM ¼öÁý, ¼­ºñ½º º¹±¸ ¿öÅ©Ç÷οì, Ä¿¹Â´ÏÄÉÀÌ¼Ç Ç¥ÁØÈ­¿¡ ´ëÇÑ ±â°üÀÇ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÁöºÒÀÚ¿Í °í¿ëÁÖ ¿ª½Ã ȯÀÚ °æÇèÀ» Ç÷£ ¼±Åðú ÇýÅà ¼³°èÀÇ °áÁ¤ ¿äÀÎÀ¸·Î »ï°í ÀÖÀ¸¸ç, ÇコÄÉ¾î »ýŰè Àü¹Ý¿¡ °ÉÃÄ Á¢Á¡ÀÇ µðÁöÅÐÈ­¿Í ¸¶ÂûÀ» ÁÙ¿©¾ß ÇÑ´Ù´Â ¾Ð·ÂÀ» °¡Çϰí ÀÖ½À´Ï´Ù.

±â¼ú º¥´õ, ½ºÅ¸Æ®¾÷, EHR Ç÷§ÆûÀº ÀÓ»ó ½Ã½ºÅÛ, À繫 ¿öÅ©Ç÷οì, CRM Ç÷§Æû°ú ÅëÇյǴ ¸ðµâ½Ä »óÈ£ ¿î¿ë °¡´ÉÇÑ ¼Ö·ç¼ÇÀ» ±¸ÃàÇÏ¿© ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ¹èÆ÷, ¸ð¹ÙÀÏ ¿ì¼± ÀÎÅÍÆäÀ̽º, AI ±â´É, Á¢±Ù¼º ¹× È®À强À» È®ÀåÇϰí ÀÖ½À´Ï´Ù. ÇコÄɾî´Â °³ÀÎÈ­, »ó½Ã ¿¬°á, µ¥ÀÌÅÍ ±â¹Ý ¼­ºñ½º ¸ðµ¨·Î ÁøÈ­Çϰí ÀÖÀ¸¸ç, ȯÀÚ °æÇè ±â¼úÀº °æÀï·Â ÀÖ´Â ¾çÁúÀÇ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϱâ À§ÇÑ ¼±ÅÃÀÌ ¾Æ´Ñ ±âº»ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

±¸¼º¿ä¼Ò(ȯÀÚ °æÇè Á¶»ç, µðÁöÅРȯÀÚ Âü¿©, ȯÀÚ ÄÁÅü¾ÅÍ Æ®·¡Å·, ȯÀÚ ÄÁÅü¾ÅÍ, ȯÀÚ ¶óÀ̺ê äÆÃ Âü¿©, ±âŸ ±¸¼º¿ä¼Ò), ÃÖÁ¾»ç¿ë(º´¿ø ÃÖÁ¾»ç¿ë, Áø·á¼Ò ÃÖÁ¾»ç¿ë, ÀçÅà ÄÉ¾î ½Ã¼³ ÃÖÁ¾»ç¿ë)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Patient Experience Technology Market to Reach US$415.4 Million by 2030

The global market for Patient Experience Technology estimated at US$245.3 Million in the year 2024, is expected to reach US$415.4 Million by 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. Patient Experience Surveys, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$123.7 Million by the end of the analysis period. Growth in the Digital Patient Engagement segment is estimated at 10.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$66.8 Million While China is Forecast to Grow at 14.5% CAGR

The Patient Experience Technology market in the U.S. is estimated at US$66.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$93.1 Million by the year 2030 trailing a CAGR of 14.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 8.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Patient Experience Technology Market - Key Trends & Drivers Summarized

How Is Patient Experience Technology Reshaping Engagement Across the Care Continuum?

Patient experience technology has evolved from being a hospital-centric amenity to a strategic enabler of patient-centered care across the healthcare continuum. This broad and fast-growing segment includes digital tools that optimize communication, satisfaction, feedback, navigation, and care personalization. From check-in kiosks and mobile wayfinding apps to AI-powered chatbots and real-time feedback platforms, patient experience technology aims to make care journeys smoother, more informed, and more interactive-ultimately improving clinical outcomes and operational efficiency.

The rise in consumerization of healthcare has shifted patient expectations toward transparency, convenience, and digital empowerment. Patients now demand experiences on par with what they receive from banking, retail, or travel services-instant access, digital control, and 24/7 support. As a result, hospitals and health systems are investing in unified patient engagement platforms that integrate appointment scheduling, payment portals, health education modules, post-discharge instructions, and remote support via a single mobile app interface.

Patient-reported experience measures (PREMs) are gaining traction as key quality benchmarks, influencing not only hospital rankings but also reimbursement under value-based care models. In response, healthcare providers are deploying digital survey tools, real-time net promoter score (NPS) dashboards, and analytics platforms to track satisfaction in near real time. These technologies help detect service bottlenecks, reduce wait times, improve staff responsiveness, and flag at-risk patients who require more touchpoints-making them critical tools for competitive differentiation in today’s outcome-focused care environment.

Which Digital Interfaces and AI Tools Are Enhancing the Patient Journey?

The deployment of patient-facing digital interfaces-such as self-service kiosks, bedside infotainment systems, and multilingual virtual assistants-is transforming how patients interact with hospitals and clinics. Kiosks equipped with facial recognition, contactless check-in, and insurance validation streamline the arrival process and reduce administrative burden. Mobile-based wayfinding solutions help patients navigate large hospital campuses, minimizing confusion and stress. Interactive room tablets and infotainment consoles offer access to health content, dietary options, and care schedules-empowering inpatients and improving satisfaction scores.

Artificial intelligence is amplifying the impact of patient experience platforms through chatbots, predictive analytics, and natural language processing. AI chatbots are used in triage and scheduling, guiding patients to the right provider or test without human intervention. Voice assistants and NLP engines are being deployed for multilingual support, accessibility for vision-impaired patients, and real-time transcription of verbal feedback. Predictive models identify patients at risk of disengagement, no-shows, or poor compliance, allowing proactive outreach and personalized support through text, call, or app notifications.

Moreover, virtual care and remote monitoring platforms are extending the patient experience beyond the hospital. Wearables and home health kits track recovery progress, transmit symptom updates, and provide medication reminders, improving adherence and continuity of care. Patient portals are integrating asynchronous communication, teleconsultation history, prescription refills, and access to digital health records-empowering users with transparency and control. Collectively, these tools bridge the gap between episodic and continuous care, making the experience more longitudinal and relational.

Which Provider Types and Regional Health Systems Are Leading in Adoption?

Adoption of patient experience technologies is being led by large hospital systems, academic medical centers, ambulatory care chains, and payer-provider hybrid networks. Integrated delivery networks (IDNs) are increasingly prioritizing digital experience platforms as part of their broader digital front-door strategy. These platforms unify patient outreach, communication, intake, and follow-up-aligning with population health goals and value-based reimbursement models.

Ambulatory care providers and outpatient surgery centers are investing in automated feedback systems and self-service tools to optimize throughput and boost patient loyalty. Telehealth providers and digital-first clinics are natively deploying these technologies, integrating virtual waiting rooms, chatbot triage, and digital consent forms into their core offerings. Meanwhile, payers are also entering the patient experience space by offering member apps, virtual coaching, and customer service AI tools to enhance retention and satisfaction.

Regionally, the U.S. leads the market due to value-based reimbursement mandates, competitive provider ecosystems, and high patient expectations. Europe is accelerating adoption with digital health strategies such as the NHSX program in the UK and France’s Ma Sante 2022, which emphasize patient-centric digital transformation. Asia-Pacific is witnessing strong growth, particularly in urban China, Singapore, and India, where rising health-tech investment is driving mobile-first patient engagement. Latin America and the Middle East are emerging markets with government-backed hospital modernization projects that include patient experience KPIs.

What Forces Are Driving the Growth of the Patient Experience Technology Market?

The growth in the global patient experience technology market is driven by the increasing focus on value-based care, rising consumer expectations, digital transformation of healthcare delivery, and the demand for real-time feedback and personalized support. With healthcare competition intensifying, providers are turning to patient experience tools not only for compliance and satisfaction, but as critical levers for growth, retention, and care coordination.

Government mandates and accreditation bodies are incorporating patient experience scores into performance measurement frameworks, driving institutional investment in real-time PREMs collection, service recovery workflows, and communication standardization. Payers and employers are also prioritizing member experience as a determinant of plan selection and benefit design, creating pressure across the healthcare ecosystem to digitize touchpoints and reduce friction.

Technology vendors, startups, and EHR platforms are responding by building modular, interoperable solutions that integrate with clinical systems, financial workflows, and CRM platforms. Cloud deployment, mobile-first interfaces, and AI capabilities are expanding accessibility and scalability. As healthcare evolves into a personalized, always-connected, and data-informed service model, patient experience technology is becoming foundational-not optional-in delivering competitive, high-quality care.

SCOPE OF STUDY:

The report analyzes the Patient Experience Technology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Patient Experience Surveys, Digital Patient Engagement, Patients Contact Center Tracking, Patients Contact Centers, Patient Live Chat Engagement, Other Components); End-Use (Hospitals End-Use, Clinics End-Use, Home Care Settings End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â